Losartan Market 2028 By Indication, Route of Administration and Geography | The Insight Partners

report image

Losartan Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Indication (Blood Pressure, Stroke, Heart Disease); Route of Administration (Oral) and Geography

Report Code: TIPRE00017473 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming


Losartan is an angiotensin II receptor blocker used to treat mild to moderate hypertension as well as stroke in some cases. Losartan is also been used in slowing down long term kidney damage due to type II diabetes. Losartan by blocking angiotensin II receptor help arteries and blood vessels to relax and widen which makes blood flow easy through them. Losartan is available with oral route of administration. The side effects of losartan includes, upper respiratory tract infections, dizziness, stuffy nose, back pain and fatigue.


The key market drivers for Losartan Market Includes, rising prevalence of cardiovascular disorders such as, hypertension, stroke, heart failure. Moreover, increasing geriatric population across the globe is also fueling the market growth. Whereas, wide range of side effects from losartan is expected to restrain market growth during the forecast period.


The "Losartan Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Losartan market with detailed market segmentation by indication and route of administration. The Losartan Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Losartan Market and offers key trends and opportunities in the market.


The Losartan Market is segmented on the basis of indication and route of administration. On the basis of indication the market is segmented as, blood pressure, stroke and heart disease. And on the basis of route of administration the market is segmented as by oral route.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Losartan Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Losartan Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Losartan Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Losartan Market in these regions.

Get more information on this report :


The report covers key developments in the Losartan Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Losartan Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Losartan market in the global market. Below mentioned is the list of few companies engaged in the Losartan Market.
The report also includes the profiles of key players in Losartan Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •  Torrent Pharmaceuticals
  •  Macleods Pharmaceuticals
  •  Merck
  •  Teva Pharmaceuticals
  •  Lupin
  •  Cipla
  •  Sandoz
  •  Sun Pharmaceuticals
  •  Unichem Laboratories
  •  Dr. Reddy's Laboratories

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Get more information on this report :

The List of Companies

1. Torrent Pharmaceuticals
2. Macleods Pharmaceuticals
3. Merck
4. Teva Pharmaceuticals
5. Lupin
6. Cipla
7. Sandoz
8. Sun Pharmaceuticals
9. Unichem Laboratories
10. Dr. Reddy's Laboratories
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market


Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000 $2700
  • $4550 $4095
  • $6550 $5568
  • $8550 $6840

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount